Sign Out
Patients with known hypersensitivity to sodium rabeprazole, substituted benzimidazoles or to any excipient used in Pariet.
Use in pregnancy & lactation: There are no data on the safety of rabeprazole in human pregnancy.
Reproduction studies performed in rats and rabbits have revealed no evidence of impaired fertility or harm to the fetus due to sodium rabeprazole, although low feto-placental transfer occurs in rats. Pariet is contraindicated during pregnancy.
It is not known whether sodium rabeprazole is excreted in human breast milk. No studies in lactating women have been performed. Sodium rabeprazole is, however, excreted in rat mammary secretions. Therefore, Pariet should not be used during breastfeeding.
